Skip to main content
. 2021 Nov 8;30(2):509–518. doi: 10.1016/j.ymthe.2021.11.005

Figure 4.

Figure 4

PDMS-2 score, by patient and chronological age

PDMS-2 scores of individual patients (N = 26) at baseline and 1 year after gene therapy. Each line graph shows PDMS-2 total score in each patient. The first data point for each patient indicates baseline score at the time of eladocagene exuparvovec administration.